These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2971877)

  • 1. Suppressor T cells in myasthenia gravis.
    Clementi F; Gotti C; Mori L; Ricciardi-Castagnoli P
    Monogr Allergy; 1988; 25():41-9. PubMed ID: 2971877
    [No Abstract]   [Full Text] [Related]  

  • 2. Suppressor T cells in myasthenia gravis and antibodies to acetylcholine receptor.
    Lisak RP; Laramore C; Levinson AI; Zweiman B; Moskovitz AR
    Ann Neurol; 1986 Jan; 19(1):87-9. PubMed ID: 2936299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antibody against synthetic peptide corresponding to alpha-subunit residues 128-142 of nicotinic acetylcholine receptor (AChR): the significance in myasthenia gravis (MG)].
    Shibuya N; Kanazawa H; Uyemura K
    Rinsho Shinkeigaku; 1988 Mar; 28(3):315-9. PubMed ID: 3402139
    [No Abstract]   [Full Text] [Related]  

  • 4. Enzyme-linked immunosorbent assay for antibody against the nicotinic acetylcholine receptor in human myasthenia gravis.
    Kawanami S; Tsuji R; Oda K
    Ann Neurol; 1984 Feb; 15(2):195-200. PubMed ID: 6367620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress in the understanding of myasthenia gravis pathogenesis.
    Heilbronn E
    Prog Clin Biol Res; 1980; 39():391-405. PubMed ID: 6995993
    [No Abstract]   [Full Text] [Related]  

  • 6. Myasthenia gravis, the acetylcholine receptor and the immune response.
    Barkas T
    Int J Immunopharmacol; 1979; 1(4):263-71. PubMed ID: 162144
    [No Abstract]   [Full Text] [Related]  

  • 7. Humoral immunity in myasthenia gravis: immunoglobulin class, affinity, and antigenic site.
    Tindall RS
    Trans Am Neurol Assoc; 1979; 104():16-8. PubMed ID: 553397
    [No Abstract]   [Full Text] [Related]  

  • 8. [Myasthenia gravis; clinical aspects, pathophysiology and treatment].
    Oosterhuis HJ
    Ned Tijdschr Geneeskd; 1983 Sep; 127(39):1765-71. PubMed ID: 6314161
    [No Abstract]   [Full Text] [Related]  

  • 9. alpha-Bungarotoxin displacing antibody in myasthenia gravis.
    Barkas T; Simpson JA
    J Clin Lab Immunol; 1982 Nov; 9(2):113-7. PubMed ID: 7154056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental myasthenia gravis is inhibited by receptor-antireceptor complexes.
    Barkas T; Simpson JA
    J Clin Lab Immunol; 1982 Apr; 7(3):223-7. PubMed ID: 7097749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental myasthenia gravis: a model of receptor disease.
    Takamori M; Kasai M
    Int J Neurol; 1980; 14(1):47-60. PubMed ID: 6293991
    [No Abstract]   [Full Text] [Related]  

  • 12. Determinant selection in murine experimental autoimmune myasthenia gravis. Effect of the bm12 mutation on T cell recognition of acetylcholine receptor epitopes.
    Infante AJ; Thompson PA; Krolick KA; Wall KA
    J Immunol; 1991 May; 146(9):2977-82. PubMed ID: 1707927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antibodies to acetylcholine receptor. Diagnosis and therapeutic interest in myasthenia gravis (author's transl)].
    de Crousaz G
    Ann Chir; 1980 Mar; 34(3):188-92. PubMed ID: 7369693
    [No Abstract]   [Full Text] [Related]  

  • 14. The autoimmune T and B cell repertoires in monozygotic twins discordant for myasthenia gravis.
    Kakoulidou M; Ahlberg R; Yi Q; Giscombe R; Pirskanen R; Lefvert AK
    J Neuroimmunol; 2004 Mar; 148(1-2):183-91. PubMed ID: 14975600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of T cell subpopulations and recombinant interleukin (IL)-2 on peripheral B cell function in patients with myasthenia gravis.
    Zhang J; Zhou WB; Wang HL; Guo SS
    Hum Antibodies; 1997; 8(2):90-4. PubMed ID: 9289393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune regulation in myasthenia gravis: evidence for an increased suppressor T-cell population.
    Miller AE; Hudson J; Tindall RS
    Ann Neurol; 1982 Oct; 12(4):341-7. PubMed ID: 6216848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Nicotinic cholinergic receptor and myasthenia gravis].
    Tu LH
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1983 Aug; 16(4):250-3. PubMed ID: 6315322
    [No Abstract]   [Full Text] [Related]  

  • 18. Heterogeneity of acetylcholine receptors in denervated muscle: interactions of receptors with immunoglobulin from patients with myasthenia gravis.
    Mittag TW; Tormay A; Massa T
    Mol Pharmacol; 1978 Jan; 14(1):60-8. PubMed ID: 625290
    [No Abstract]   [Full Text] [Related]  

  • 19. Myasthenia gravis. T epitopes on the delta subunit of human muscle acetylcholine receptor.
    Protti MP; Manfredi AA; Wu XD; Moiola L; Howard JF; Conti-Tronconi BM
    J Immunol; 1991 Apr; 146(7):2253-61. PubMed ID: 1706391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding and blocking antibodies to the human acetylcholine receptor: are they selected in various myasthenia gravis forms?
    Morel E; Vernet-der Garabedian B; Eymard B; Raimond F; Bustarret FA; Bach JF
    Immunol Res; 1988; 7(3):212-7. PubMed ID: 3193008
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.